Opus Genetics, Inc.

US$4.18As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:IRDHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (6.32%)
Div yield —
ROE (4796.52%)
Biotechnology
Beta (5Y) 0.81
PE TTM —
TSR TTM 81.74%
Mkt cap US$347.8M
ROIC (70.88%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$5.41
29.53%
(68.86%)
Sell 7|4|4|1|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.05
0.05
0.05
0.05
16.97%
15.07%
11.88%
0.08%
Revenue$M
16.58
17.31
17.79
17.69
(2.74%)
0.03%
4.90%
5.42%
Peers (US$347.8M)
Cap (US$)
PE
344.6M
—
Capital
TTM
5Y
10Y
Leveragex
0.545
0.401
0.379
EBIT/Intx
4.093
0.144
0.118
Own earn%
27.25
(48.72)
(46.89)
Sh yield%
46.17
47.36
44.23
Owners
Insiders/Inst%
6.44
76.99
Short interest%
4.48
SBC / revenue%
0.97
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
15–21
$1 testx
—
Incr. ROIC%
7